ARCHIVES

Cancer Control Contract Negotiations To Start Soon; Two Weaknesses Occur In Many Proposals

This article is from The Cancer Letter archive.

Vol. 01 No. 10 | March 7, 1975

Download PDF Visit The Full Archive

Related Articles

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

November 29, 2013

Strict System For Protection Of Human Subjects Ordered In Wake Of NIH Investigation

August 9, 1991

Clearinghouse Group Selects 10 More Compounds To Test

January 13, 1978

New Abiraterone Acetate Results Show Greater Benefit Than Before

June 24, 2011

FDA’s New Guideline Proposal Meets More NCI Objections

March 19, 1976

CPRU Program Gets Basic Concept Approval

October 2, 1987